Could a common supplement help kids with NF1 think and move better?
NCT ID NCT04481035
First seen Apr 24, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study tested whether N-acetylcysteine (NAC), an over-the-counter antioxidant, could improve learning, behavior, and motor skills in children with neurofibromatosis type 1 (NF1). Five children aged 8–16 took part in a double-blind, placebo-controlled trial. The goal was to see if NAC could ease symptoms like attention problems and poor coordination, but the study was very small and exploratory.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.